Skip to main content

Diagnostic options Β· UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 1096–1110 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2925
WDR19 Gene Cranioectodermal Dysplasia Type 4 Genetic Test

This test detects pathogenic variants, including single nucleotide variants, indels, and copy number variants, within the WDR19 gene associated with cranioectodermal dysplasia type...

Whole Blood (3 mL EDTA), Extracted DNA, or One Drop Blood on FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Variants (SNVs) in WDR19 gene", "Insertions/Deletions (Indels) in WDR19 gene", "Copy Number Variants (CNVs) in WDR19 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Clinical suspicion of cranioectodermal dysplasia type 4 (CED4)", "Family history of CED4", "Need for genetic confirmation for management and counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 98747-9 ICD-10: Q87.8
Clinical summary
This test detects pathogenic variants, including single nucleotide variants, indels, and copy number variants, within the WDR19 gene associated with cranioectodermal dysplasia type 4.
TEST-1313
Whole Genome Genetic Mapping Test

This test evaluates the entire genome for single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) to assess genetic predispositions.

Peripheral Whole Blood 8 weeks from sample collection 30,000.00 AED
View
View test specifications and preparation
What it measures
["Single Nucleotide Polymorphisms (SNPs)", "Copy Number Variations (CNVs)", "Pharmacogenomic profiles", "Ancestry markers"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Proactive health screening", "Pharmacogenomic profiling", "Ancestry analysis", "Carrier screening", "Pediatric developmental concerns"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Z13.89
Clinical summary
This test evaluates the entire genome for single nucleotide polymorphisms (SNPs) and copy number variations (CNVs) to assess genetic predispositions.
TEST-3448
Wilson Disease ATP7B Gene Mutation Detection Test

This test identifies pathogenic variants in the ATP7B gene to confirm a diagnosis of Wilson disease.

Whole Blood Up to 2 months from sample receipt 6,600.00 AED
View
View test specifications and preparation
What it measures
["ATP7B gene mutations", "Pathogenic variants"]
Parameters
[]
Preparation
["No special fasting required", "No medication changes required"]
Indications
["Symptomatic patients with suspected Wilson disease", "Presymptomatic screening of at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-0 ICD-10: E83.01
Clinical summary
This test identifies pathogenic variants in the ATP7B gene to confirm a diagnosis of Wilson disease.
TEST-3434
Wilson Disease Panel Test

This diagnostic test evaluates copper metabolism by measuring serum ceruloplasmin, total serum copper, and 24-hour urine copper levels.

Whole blood (serum) and 24-hour urine Next day (Mon–Sat, by 6 PM cutoff) 800.00 AED
View
View test specifications and preparation
What it measures
["Serum Ceruloplasmin", "Total Serum Copper", "24-Hour Urine Copper"]
Parameters
[{"name": "Serum Ceruloplasmin", "reference_range": null}, {"name": "Total Serum Copper", "reference_range": null}, {"name": "24-Hour Urine Copper", "reference_range": null}]
Preparation
["Avoid barium contrast for 96 hours", "Use powderless gloves during collection", "Use a metal-free urine container", "Continue regular diet and medications", "Inform phlebotomist about high-dose zinc or copper supplements", "Fasting is not mandatory"]
Indications
["Unexplained liver disease (elevated transaminases, hepatomegaly, acute hepatitis)", "Neuropsychiatric symptoms (tremor, dystonia, dysarthria, personality changes)", "Kayser-Fleischer rings on slit-lamp exam", "Family history of Wilson disease", "Unexplained extrapyramidal symptoms under 40", "Recurrent hepatic dysfunction not attributable to viral or autoimmune causes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95123-6 ICD-10: E83.01
Clinical summary
This diagnostic test evaluates copper metabolism by measuring serum ceruloplasmin, total serum copper, and 24-hour urine copper levels.
TEST-4723
WNT1 Gene Osteogenesis Imperfecta Type XV Genetic Test

This test identifies pathogenic variants in the WNT1 gene associated with Osteogenesis Imperfecta Type XV.

Whole Blood (EDTA) or Blood Spot (FTA Card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNT1 gene pathogenic variants"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of recent blood transfusions or stem cell transplants"]
Indications
["Suspected Osteogenesis Imperfecta Type XV", "Family history of Osteogenesis Imperfecta"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81723-5 ICD-10: Q78.0
Clinical summary
This test identifies pathogenic variants in the WNT1 gene associated with Osteogenesis Imperfecta Type XV.
TEST-2224
WNT7A Gene Sequencing (NGS) Test

This test evaluates the WNT7A gene for variants associated with Schinzel phocomelia syndrome.

Peripheral whole blood (EDTA) or FTA card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["WNT7A gene sequence", "Copy Number Variations (CNVs) in WNT7A"]
Parameters
[]
Preparation
[]
Indications
["Suspected Schinzel phocomelia syndrome", "Family history of limb deficiency disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81231-0 ICD-10: Q87.8
Clinical summary
This test evaluates the WNT7A gene for variants associated with Schinzel phocomelia syndrome.
TEST-1052
WS1 Full Gene Sequence Analysis (Wolfram Syndrome, DIDMOAD) Test

This test evaluates the WFS1 gene for pathogenic variants associated with Wolfram syndrome (DIDMOAD). It identifies genetic mutations that cause this rare disorder.

Peripheral blood, amniotic fluid, chorionic villi, cord blood 4–6 weeks 4,800.00 AED
View
View test specifications and preparation
What it measures
["WFS1 gene sequence", "Pathogenic variants (SNVs, small indels)"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Suspected Wolfram syndrome based on clinical presentation", "Family history of Wolfram syndrome", "Confirmation of diagnosis at a molecular level"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 95419-5 ICD-10: Q87.8, Z15.0, Z13.7
Clinical summary
This test evaluates the WFS1 gene for pathogenic variants associated with Wolfram syndrome (DIDMOAD). It identifies genetic mutations that cause this rare disorder.
TEST-4486
XPA Gene Xeroderma Pigmentosum Group A (XPA) Genetic Test

This test identifies germline mutations in the XPA gene associated with Xeroderma Pigmentosum Group A.

Peripheral whole blood 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["XPA gene mutations", "SNVs", "Indels", "CNVs"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments required", "Genetic counseling and pedigree chart review mandatory"]
Indications
["Siblings of confirmed Xeroderma Pigmentosum patients", "Individuals with unexplained severe photosensitivity", "Family history of Xeroderma Pigmentosum"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 8827-2 ICD-10: Q82.1
Clinical summary
This test identifies germline mutations in the XPA gene associated with Xeroderma Pigmentosum Group A.
TEST-4461
XPC Gene (Xeroderma Pigmentosum Group C) Genetic Test

This genetic test analyzes the XPC gene for pathogenic variants associated with Xeroderma Pigmentosum Group C, a disorder causing extreme UV sensitivity and increased skin cancer r...

Whole Blood, FTA Card, or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the XPC gene"]
Parameters
[]
Preparation
["No fasting or medication withdrawal is required", "Mandatory pre-test genetic counseling session"]
Indications
["Suspected Xeroderma Pigmentosum Group C", "Family history of Xeroderma Pigmentosum", "Extreme photosensitivity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94233-5 ICD-10: Q82.1
Clinical summary
This genetic test analyzes the XPC gene for pathogenic variants associated with Xeroderma Pigmentosum Group C, a disorder causing extreme UV sensitivity and increased skin cancer risk.
TEST-2334
XRCC4 Gene Genetic Test (Short Stature, Microcephaly, Endocrine Dysfunction)

This test evaluates the XRCC4 gene for pathogenic mutations linked to specific developmental and endocrine conditions.

Peripheral whole blood or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["XRCC4 gene sequence", "Pathogenic variants in XRCC4"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling session", "Documentation of family history (pedigree)", "Obtain informed consent"]
Indications
["Unexplained growth failure", "Microcephaly", "Hormonal abnormalities", "Family history suggesting XRCC4-related disorder"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81321-7 ICD-10: Q02, R62.52
Clinical summary
This test evaluates the XRCC4 gene for pathogenic mutations linked to specific developmental and endocrine conditions.
TEST-3576
YAP1 Gene Coloboma, Ocular, with or without Hearing Impairment, Cleft Lip/Palate, and/or Mental Retardation Genetic Test

This test evaluates the YAP1 gene for pathogenic variants associated with coloboma-related syndromes.

Whole Blood (Peripheral) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the YAP1 gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variants (CNVs)"]
Parameters
[]
Preparation
["A detailed clinical history focusing on ocular, auditory, craniofacial, and developmental milestones is mandatory.", "A genetic counseling session is required to construct a pedigree chart.", "Informed consent must be documented."]
Indications
["Individuals with clinical features suggestive of YAP1-related disorders", "Family history of YAP1-related conditions", "Prenatal diagnosis in high-risk pregnancies"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82382-9 ICD-10: Q12.2, Q13.0, Q14.8
Clinical summary
This test evaluates the YAP1 gene for pathogenic variants associated with coloboma-related syndromes.
TEST-2300
ZBTB16 Gene Sequencing (NGS) Test

This diagnostic test evaluates the ZBTB16 gene for pathogenic variants associated with skeletal defects, genital hypoplasia, and intellectual disability.

Peripheral whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZBTB16 gene"]
Parameters
[{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}]
Preparation
["No special preparation is needed", "Genetic counselling session recommended prior to testing"]
Indications
["Individuals presenting with clinical features suggestive of ZBTB16-related disorders", "Family history of ZBTB16-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 38075-4 ICD-10: Z13.79
Clinical summary
This diagnostic test evaluates the ZBTB16 gene for pathogenic variants associated with skeletal defects, genital hypoplasia, and intellectual disability.
TEST-5962
ZC4H2 Gene Wieacker‑Wolff Syndrome Genetic Test

This test identifies mutations in the ZC4H2 gene associated with Wieacker-Wolff syndrome.

Whole Blood (Peripheral), FTA Card Dried Blood Spot, or Extracted Genomic DNA 3 – 4 weeks (expedited available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZC4H2 gene", "Coding and splice-site variants"]
Parameters
[]
Preparation
["No fasting required", "No medication changes required"]
Indications
["Suspected Wieacker-Wolff syndrome", "Family history of Wieacker-Wolff syndrome", "X-linked neurodevelopmental disorder investigation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79255-8 ICD-10: Q87.8
Clinical summary
This test identifies mutations in the ZC4H2 gene associated with Wieacker-Wolff syndrome.
TEST-2756
ZEB2 Gene Hirschsprung Disease Genetic Test

This test evaluates the ZEB2 gene for pathogenic variants associated with Hirschsprung disease and Mowat-Wilson syndrome.

Whole Blood (EDTA), Extracted DNA, Dried Blood FTA Card 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZEB2 gene", "Point mutations", "Small insertions and deletions", "Copy number variants"]
Parameters
[]
Preparation
[]
Indications
["Paediatric patients with symptoms of Hirschsprung disease", "Neonates with delayed passage of meconium (>48 hours)", "Individuals with a family history of ZEB2-related syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 44397-5 ICD-10: Q43.1
Clinical summary
This test evaluates the ZEB2 gene for pathogenic variants associated with Hirschsprung disease and Mowat-Wilson syndrome.
TEST-4213
ZFPM2 Gene Diaphragmatic Hernia Type 3 Genetic Test

This test identifies pathogenic variants in the ZFPM2 gene associated with congenital diaphragmatic hernia (CDH) type 3.

Peripheral whole blood (EDTA), buccal swab, or dried blood spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ZFPM2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "No medication adjustments needed"]
Indications
["Confirmation of genetic cause for CDH type 3", "Family history of CDH type 3", "Recurrence risk assessment", "Prenatal planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: Q79.0
Clinical summary
This test identifies pathogenic variants in the ZFPM2 gene associated with congenital diaphragmatic hernia (CDH) type 3.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area